An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration ...

The announcement was welcome news for those with major depressive disorder, affecting an estimated 8.3% of the adult ...

An asthma drug taken by hundreds of thousands of Australians could increase the risk of suicide, research suggests.

The U.S. Food and Drug Administration has approved a nasal spray that is known to help treat depression.

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

In today's Health Alert, the FDA has approved the first stand-alone nasal spray to treat drug-resistant depression.

CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at least two oral ...

A man has been accused of operating a drug factory at his apartment in Waterbury where authorities reportedly seized multiple types of narcotics during a raid last week. The search was carried out ...

A one-time nasal spray has been approved by the Food and Drug Administration as a standalone treatment for depression.

A woman who suffered from severe migraines died after taking an overdose of a drug prescribed to treat them. Much-loved Katie ...

The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with ma ...